相关实验视频
Updated: Sep 18, 2025
08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.9K
拉帕米辛减轻了因线粒体功能障碍和Syntaxin中SERCA低活性引起的心力衰竭12/13缺陷模型
Run-Zhou Yang1, Fang Li2, Jiao Liu3,4
1Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|June 26, 2025
概括
合成素12/13 (STX12) 缺乏导致心力衰竭,因为它破坏了线粒体功能和金属平衡. 拉巴胺治疗通过恢复线粒体和质网膜Ca2+-ATPase (SERCA) 活性提供了潜在的治疗方法.
科学领域:
- 心血管生物学 心血管生物学
- 线粒体生理学线粒体生理学
- 细胞的新陈代谢
背景情况:
- 合成素12/13 (STX12) 是一种在大脑和心脏中发现的蛋白质家族成员,对囊泡循环至关重要.
- STX12在心血管生理学中的特定作用尚不清楚.
研究的目的:
- 研究STX12在心血管健康中的功能.
- 阐明STX12缺乏引起的心脏功能障碍背后的分子机制.
- 探索STX12相关心肌病的潜在治疗干预措施.
主要方法:
- 利用斑马鱼和小鼠模型研究STX12功能丧失.
- 分析了心脏形态,线粒体功能和细胞处理.
- 研究了对STX12缺陷模型的拉巴素治疗的影响.
主要成果:
- 失去了STX12导致心周胀,心脏形和心力衰竭.
- 由于STX12的枯竭,线粒体形态受损,铁和水平降低,ATP的产生减少.
- 缺乏STX12的心肌细胞表现出延长的复极化,原因是质网膜Ca2+-ATPase (SERCA) 活性降低.
- 拉巴胺治疗改善了线粒体功能,增强了SERCA活性,并减少了压力标志物.
结论:
- STX12对于心肌细胞的能量代谢和金属恒温至关重要.
- 拉巴胺通过通过特定的分子通路 (TFEB-PGC1α和CAMKII-phospholamban) 增强线粒体功能,自和SERCA活性,在治疗心肌病症方面表现有前途.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
01:26Heart Failure Drugs: Inotropic Agents
743
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
743